Immune Design: 3Q Earnings Snapshot
SEATTLE (AP) _ Immune Design Corp. (IMDZ) on Tuesday reported a loss of $14 million in its third quarter.
The Seattle-based company said it had a loss of 29 cents per share.
The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 32 cents per share.
The biotechnology company posted revenue of $462,000 in the period.
In the final minutes of trading on Tuesday, the company’s shares hit $1.49. A year ago, they were trading at $4.45.